貨號：GS40064

Bedinvetmab is a caninized (canine/human) monoclonal antibody specifically designed for veterinary medicine. It targets and neutralizes Nerve Growth Factor (NGF) in dogs. By binding to NGF, it blocks its interaction with the TrkA receptor, thereby inhibiting the pain signaling pathway associated with osteoarthritis (OA). It is approved in various regions (including the EU and the U.S. under the brand name Librela?) for the control of pain associated with osteoarthritis in dogs, administered as a monthly subcutaneous injection.